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Three-Dimensional Engineered Bone–Ligament–Bone
Constructs for Anterior Cruciate Ligament Replacement
Jinjin Ma, M.S.,1 Michael J. Smietana, M.S.,2 Tatiana Y. Kostrominova, Ph.D.,3 Edward M. Wojtys, M.D.,4
Lisa M. Larkin, Ph.D.,2,5 and Ellen M. Arruda, Ph.D.1,2,6
The anterior cruciate ligament (ACL), a major stabilizer of the knee, is commonly injured. Because of its intrinsic
poor healing ability, a torn ACL is usually reconstructed by a graft. We developed a multi-phasic, or bone–
ligament–bone, tissue-engineered construct for ACL grafts using bone marrow stromal cells and sheep as a
model system. After 6 months in vivo, the constructs increased in cross section and exhibited a well-organized
microstructure, native bone integration, a functional enthesis, vascularization, innervation, increased collagen
content, and structural alignment. The constructs increased in stiffness to 52% of the tangent modulus and 95%
of the geometric stiffness of native ACL. The viscoelastic response of the explants was virtually indistinguishable
from that of adult ACL. These results suggest that our constructs after implantation can obtain physiologically
relevant structural and functional characteristics comparable to those of adult ACL. They present a viable option
for ACL replacement.
Introduction
Knee injuries accounted for 400,000 physician officevisits in the United States in 2005.1 Worldwide, the
proportion of knee injuries to young sports players that
require surgery is estimated to be 17%–61%,2 and in the
United States, knee injuries are now the leading cause of
high school sports-related surgeries.3 In addition to the
high costs associated with the surgery itself, acute knee
injury is a risk factor for osteoarthritis (OA).4–6 Anterior
cruciate ligament (ACL) reconstruction surgeries, involving
bone/ligament autografts or allografts, are performed in
the United States at a rate of nearly 350,000 per year and
acute care alone requires for $6 billion annually.7 Current
knee ligament replacement strategies involve either ACL
allografts from cadavers or autografts of the patients’ own
patellar or hamstring tendons. Outcomes for ACL recon-
struction with these techniques are limited by graft avail-
ability, risk of rejection, and increased donor site morbidity.
In addition, the region of the graft or engineered material
within the bone tunnel may not fully integrate with native
tissue.8,9 The initial response of the body to either grafts or
current tissue engineering approaches results in reduced
stiffness of the replacement.10 Many grafts function as me-
chanical springs that span the gap between the femur and
tibia, providing stability and allowing joint motion, but do
not complete the ligamentization process or restore the
original biomechanics to the knee even 2–3 years after
surgery.8–10 In addition, the incidence of early-onset OA
within 7–14 years after knee injury is as high as 50%,5,11,12
without improved outcomes as a result of ACL recon-
struction.5,13 Thus, there is a need for a ligament graft that
will develop biochemically relevant and biomechanically
compatible interfaces with native tissue and restore the
proper biomechanics and physiological function to the lig-
ament. We have developed a multi-phasic engineered
bone/ligament co-culture with a viable bone–ligament in-
terface in vitro and the capacity to develop vascular and
neural systems14,15 in sheep that may greatly expand the
potential for ligament repair by providing a functional en-
thesis between the engineered ligament and bone and the
potential to reestablish the ACL-hamstring reflex arc.
Autografts are the current gold standard for ACL re-
placements and the patellar tendon is the most common
source of autograft tissue. However, the viscoelastic prop-
erties of the patellar tendon differ in several important ways
from those of the ACL. The initial stiffness of the patellar
tendon exceeds that of the ACL,16,17 patellar tendon strain to
failure at a given strain rate is significantly less than that of
ACL, which may lead to increased failure incidences16,17 and
Departments of 1Mechanical Engineering and 2Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
3Department of Anatomy and Cell Biology, Indiana University School of Medicine-Northwest, Gary, Indiana.
4Medsport Sports Medicine Program, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan.
5Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.
6Program in Macromolecular Science and Engineering, University of Michigan, Ann Arbor, Michigan.
TISSUE ENGINEERING: Part A
Volume 18, Numbers 1 and 2, 2012
ª Mary Ann Liebert, Inc.
DOI: 10.1089/ten.tea.2011.0231
103
the patellar tendon failure strain is more sensitive to strain
rate than the ACL failure strain; at higher strain rates the
failure strain for the patellar tendon decreases rapidly, again
leading to increased failure risks under impact loads.
Therefore, an engineered ligament that has the capacity to
develop the viscoelastic properties of the native ACL would
be an improvement over currently used patellar tendon
grafts. The compliance mismatch and dissimilar tissue in-
terface between native bone and engineered ligament are
additional existing design limitations that may impede
translation to clinical applications.18,19
These limitations have led investigators to develop
strategies to engineer ligament tissue to reduce or eliminate
the need for graft tissue altogether.20 Current tissue engi-
neering approaches usually involve seeding cells onto a
natural or synthetic scaffold that is both biocompatible and
degradable.21 Typically, the scaffold, initially mimicking
the structural and mechanical properties of the ACL,
gradually degrades and transfers the mechanical loads to
the new tissue regenerated within the scaffold. The incor-
poration of growth factors has been used to enhance cell
migration, proliferation, and collagen deposition in ACL
repair. For a detailed review of biomaterials and scaffold
designs, and growth factors currently utilized in engineer-
ing ligament tissue, refer to the following reviews.20–23 In
the approach taken here, isolated bone marrow stromal
cells (BMSCs) are differentiated along osteogenic and fi-
brogenic pathways and in doing so, generate their own
extra-cellular matrices. These matrices are then manipu-
lated by the cells via contraction to form the constructs
without artificial scaffolds. The resulting three-dimensional
(3D) multi-phasic bone–ligament–bone (BLB) constructs
exhibit the structural and functional interface characteristics
of native ACL by utilizing engineered ligament with en-
gineered bone at each end. We hypothesize that the BLB
constructs can integrate into the recipient bone to form a
mechanically viable and biochemically relevant interface
between the two tissues and allow rapid growth of the BLB
construct to attain mechanical and histological properties
that resemble those of native, adult ACL.
BMSC create an environment that diminishes immune
response and enhances regeneration. Thus, the potential to
use allogenic sources rather than autogenic sources of
BMSC exists.24 BMSCs can be easily isolated from autolo-
gous sources, may be expanded in culture while main-
taining their multipotency, and therefore serve as an
attractive candidate for tissue engineering.24–29 BMSCs also
secrete bioactive factors that inhibit scarring and apoptosis
and stimulate angiogenesis.24 BMSCs are an accessible and
biocompatible source of cells that are immunosuppressive,
especially for T-cells,24 making both autogenic and allo-
genic sources good candidates for use in regenerative
medicine. The in vitro BLB constructs that we have devel-
oped are made with BMSCs as a cell source and consist of
differentiated ligament tissue in the middle and differenti-
ated bone tissue on the ends.14,15
The purpose of this study was to engineer a 3D multi-
phasic ligament model or BLB construct that will rapidly
grow and remodel in vivo to attain biomechanical properties
of native ACL. We used these BLB constructs as ACL re-
placements in sheep, explanted them at 2, 3, 4, and 6 months
and characterized their mechanics and histology.
Methods
Animal model and animal care
Black Suffolk female sheep were used as hosts and BMSC
donors for the fabricated BLB constructs. The sheep and goat
have commonly been chosen as animal models for the
knee30–33 because of anatomical34–37 and mechanical38–41
similarities to human ACLs. These sheep were obtained from
the Michigan Livestock Exchange, various farms in the area
or intra-university transfer. All animals were acclimated to
our Sheep Research Facility at the University of Michigan for
1 week before any procedure. Sheep were allowed to free
range in the pasture until used for surgical implantation. The
animals were given access to food and water ad libitum.
Femur and tibia bones were surgically dissected under
aseptic conditions from the sheep immediately after eutha-
nasia with Fatal Plus (Vortech Pharmaceuticals), to obtain
bone marrow for BLB construct fabrication. The BLB con-
structs were implanted into the ACL site as a replacement
tissue and the animals were allowed to recover for 2, 3, 4, or
6 months before explantation. All surgical procedures were
performed in an aseptic environment with anesthesia in-
duced by intravenous injections of Ketamine and Diazepam
and sustained with inhalation of halothane gas. After any
surgical procedure, the animals were singly housed in se-
cluded pens for 2 weeks and then released back into the herd
until the date of explantation. All animal care and animal
surgeries were in accordance with The Guide for Care and
Use of Laboratory Animals (Public Health Service, 1996, NIH
Publication No. 85-23); the experimental protocol was ap-
proved by the University Committee for the Use and Care of
Animals.
Preparation of solutions and media
Unless otherwise indicated, all solutions and media were
prepared and stored at 4C before isolation and culture of
BMSC and warmed to 37C in a heated water bath imme-
diately before use. The media, with slight modifications from
Ref.14, were as follows: ligament growth medium (GMA)
consisted of 400 mL Dulbecco’s modified Eagle’s medium
(DMEM) with 100 mL fetal bovine serum (Gibco BRL), 6 ng/
mL basic fibroblast growth factor (bFGF; Peprotech),
0.13 mg/mL asc-2-phos, 0.05 mg/mL L-proline, and 5 mL
A9909 (Sigma A9909), and differentiation medium (DMA)
consisted of 460 mL DMEM with 35 mL 100% horse serum
albumin (Gibco BRL), 0.13 mg/mL asc-2-phos, 0.05 mg/mL
L-proline, 2 ng/mL transforming growth factor beta (Pe-
protech), and 5 mL A9909 (Sigma). For bone, the growth
medium and the differentiation medium were the same
GMA and DMA as ligament with the addition of 10 - 8 M
dexamethasone (DEX; Sigma-Aldrich).
Preparation of culture dishes
BLB constructs were engineered in individual 100 mm cell
culture plates following a slightly modified protocol previ-
ously developed.14 Briefly, plates were coated with 12.0 mL
of Sylgard (Dow Chemical Corporation, type 184 silicon
elastomer) and allowed to cure for 3 weeks before use. These
Sylgard-coated dishes were used for fabricating 3D con-
structs as described in detail in the following two sections.
Each of these plates was then filled with 16 mL of 25 mL of
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Dulbecco’s phosphate-buffered saline (DPBS) pH 7.2 ([Gibco
BRL Cat# 14190-144] per plate) and decontaminated with UV
light (wavelength 253.7 nm) for 90 min and placed in a 37C
5% CO2 incubator for 1 week before use.
Bone marrow stem cell isolation and expansion
Femur and tibia bones were surgically removed under
aseptic conditions from both legs. The surrounding soft tis-
sue was dissected and the proximal end of the femur and
distal end of the tibia were cut to expose the marrow. The
marrow was scooped using a spatula into a 50 mL conical
filled with DMEM (Gibco). The BMSCs were isolated and
expanded according to a protocol developed in our lab with
some slight modifications.14 The marrow was minced with
scissors, vortexed, and pelleted using centrifugation (Ac-
cuSpin FR; Beckman Coulter, Inc.) at 1000 rpm for 5 min at
25C. The supernatant was removed using aspiration. The
total mass of the bone marrow was measured. Then, the
marrow was resuspended in 8 mL GMA (previously de-
scribed) in 100-mm-diameter tissue culture dishes with 0.06 g
of bone marrow per ligament dish on average and 0.03 g of
bone marrow per bone dish on average. Eighty microliters of
bFGF was added to each bone dish and ligament dish.
Eighty microliters of DEX was added to each bone dish ad-
ditionally. The dishes were incubated at 37C, 95% humidity,
and 5% CO2. After 48 h, the nonadherent cells were removed
by feeding the plates with fresh GMA (as appropriate for
constructs under construction; ligament or bone). The ad-
herent BMSC were cultured to 80% confluence, at which time
cells were enzymatically removed from the 100 mm plate
using a 0.25% trypsin–ethylenediaminetetraacetic acid solu-
tion (Gibco) and passaged. Cells were plated onto construct
dishes within the third and fifth passages.
Preparation of self-organized bone constructs
Bone constructs were engineered following a previously
developed protocol.42 After incubation, the GMA was aspi-
rated and 2 · 105 cells, suspended in 16 mL bone GMA, and
were seeded onto 35 mm cell culture plates. The medium was
changed every 2–3 days. When the cells became confluent,
after approximately 5 days, DMA was substituted for GMA
to induce construct formation. After approximately 2 days, a
bone monolayer was formed on each dish. The monolayers
were carefully transferred from the current culture dishes to
Sylgard-coated dishes using sterilized tweezers. Two minu-
tien pins were placed on the monolayers approximately
20 mm apart in the dish to guide the assembly of 15–20 mm
long bones. The differentiation medium was changed every
2–3 days until the constructs were used for co-culturing BLB
constructs.
BLB construct formation
Eight milliliters of the cell suspension containing 2 · 105
cells/mL of ligament GMA was plated in each 100 mm cul-
ture dish. The dishes were then placed in a 37C 5% CO2
incubator and the medium was changed every 2–3 days.
After the cells become confluent, approximately three days
later, a ligament monolayer had formed on each 100 mm
culture dish. The monolayers were carefully transferred to
Sylgard-coated dishes (as described above) with sterilized
tweezers. Engineered bones (fabricated as described above)
of approximately 15–20 mm in length were pinned, using
two minutien pins, on top of the ligament monolayer, and in-
line axially so that the inner ends were 30–40 mm apart to
fabricate a 60–80 mm long BLB. At this point DMA replaced
GMA. The individual BLB constructs had a diameter of 0.6 to
0.8 mm. Within 1 week of implantation eight of these con-
structs were pinned together laterally at their bone ends to
form a larger width construct with dimensions of approxi-
mately 60 to 80 mm long, 2.8–3.2 mm in diameter. This large
lamellar construct fused together laterally before implanta-
tion and was of sufficient size for implantation as a sheep
ACL replacement. The BLB constructs did not develop a
necrotic core during this period of time in vitro.
The entire fabrication process is shown schematically in
Figure 1. BMSCs were first isolated from sheep femurs (Step
1). Cells were proliferated and differentiated into bone-like
cells and ligament-like cells using growth media and growth
factors (Step 2). Bone cells were seeded onto 35 mm cell
culture plates. Cells became confluent and a bone monolayer
was formed on each dish (Step 3). Ligament cells were see-
ded onto 100 mm cell culture plates. In the same fashion, cells
became confluent and a large ligament monolayer was
formed on each dish (Step 4). The bone monolayers were
transferred from the culture dishes to Sylgard-coated dishes
with two minutien pins placed on each monolayer approxi-
mately 20 mm apart to guide the formation of 3-D bone
constructs (Step 5). The ligament monolayers were carefully
transferred to Sylgard-coated 100 mm dishes. Two of the
engineered 3D bone constructs were pinned on top of a lig-
ament monolayer, and in-line axially so that the inner ends of
the bone constructs were 30–40 mm apart, to fabricate a 60–
80 mm long BLB (Step 6). Within 1 week before implantation
eight of these constructs were pinned together laterally at
their bone ends. Constructs fused together laterally to form a
larger width construct with dimensions of approximately 60–
80 mm long, 2.8–3.2 mm in diameter (Step 7). The BLB con-
structs did not develop a necrotic core during this period of
time in vitro. The BLB constructs were then used for im-
plantation as a sheep ACL replacement (Step 8).
Replacement of the ACL with engineered BLB
constructs in sheep
Before ACL reconstruction surgery, the sheep was placed
supine on the operating table. General anesthesia was ad-
ministered for ACL reconstruction. The surgical site was
prepared by shaving the wool, washing dirt, and debris from
the site and surgically scrubbing with povidone iodine soap
followed by multiple applications of Betadine. Sterile oph-
thalmic ointment was applied to the eyes. The body tem-
perature was maintained by placing the animal on a heat pad
and covering it with a blanket and was monitored with a
rectal thermometer. A 1-inch medial para patellar tendon
arthrotomy was used to expose the intercondylar notch and
excise the fat pad after 5 mL of Marcaine 1% with 1:200,000
epinephrine had been injected for hemostasis. The ACLwas
then excised leaving a remnant of the ACL stump on both
the femur and tibia to aid in positioning the ACL graft. The
tibial tunnel entrance was placed on the metaphyseal flare
just anterior to the medial collateral ligament and medial
to the tibial tuberosity. This medial site allowed oblique
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positioning of the tibial and femoral tunnels and avoided
locating the graft too centrally. Care was taken to avoid in-
advertent injury to the posterior cruciate ligament (PCL) or
the intrameniscal ligament anteriorly. Anatomic landmarks
to facilitate proper tibial tunnel placement include the native
ACL footprint, the PCL, the anterior horn of the lateral me-
niscus, and the medial tibial eminence. Miniature drill guides
were used to position guide wires in the center of the tibial
and femoral footprints. The femoral wire was placed through
a 1 cm incision over the posterior lateral femoral condyle, at
the metaphyseal flare. Cannulated reamers were used over
the guidewires to fashion 5–6 mm bone tunnels. The intra-
articular aperture of the tunnel was cleared with a debrider.
The graft was passed through the bone tunnels with a suture
attached to the proximal end of the graft. Minimal tension
( < 2 lbs) was applied to the graft as the proximal and distal
ends were sutured to the periosteum with the knee in 30 of
flexion. Notch impingement was ruled out by direct obser-
vation and knee range of motion was checked and recorded.
The joint was washed with saline and the incision closed
with nylon sutures after the capsule was closed with chromic
sutures. Antibiotic ointment and a dressing were applied.
During recovery, the animals were placed on a heat pad
and covered with a blanket to maintain body temperature,
respiration rate, and other vital signs were monitored until
the animal was standing. Once standing, the animal was
FIG. 1. Fabrication process of a BLB construct in vitro. BMSCs were first isolated from sheep femurs (Step 1). Cells were
proliferated and differentiated into bone-like cells and ligament-like cells using growth media and growth factors (details can be
found in the Methods Section Step 2). Bone cells were seeded onto 35 mm cell culture plates. Cells became confluent and a bone
monolayer was formed on each dish (Step 3). Ligament cells were seeded onto 100 mm cell culture plates. In the same fashion,
cells became confluent and a large ligament monolayer was formed on each dish (Step 4). The bone monolayers were trans-
ferred from the current culture dishes to Sylgard-coated dishes with two minutien pins placed on each monolayer approxi-
mately 20 mm apart to guide the formation of a 3D bone construct (Step 5). The ligament monolayers were carefully transferred
to Sylgard-coated 100 mm dishes. Two of the engineered 3D bone constructs were pinned on top of a ligament monolayer, and
in-line axially so that the inner ends of the bone constructs were 30–40 mm apart, to fabricate a 60–80 mm long BLB (Step 6).
Within 1 week of implantation eight of these constructs were pinned together laterally at their bone ends. Constructs fused
together laterally to form a larger width construct with dimensions of approximately 60–80 mm long, 2.8–3.2 mm in diameter
(Step 7). The BLB constructs did not develop a necrotic core during this period of time in vitro. The BLB constructs were then
used for implantation as a sheep ACL replacement (Step 8). BLB, bone–ligament–bone; BMSCs, bone marrow stromal cells; 3D,
three-dimensional; ACL, anterior cruciate ligament. Color images available online at www.liebertonline.com/tea
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moved to a pen and given access to food and water. Daily
monitoring of the surgical site for infection was conducted.
The sutures were removed at 14 days postsurgery.
BLB and native ACL and patellar tendon dissections
After 2, 3, 4, and 6 months of implantation, BLBs and
contralateral native ACLs were dissected for morphological
and mechanical analyses. Sheep were euthanized with Fatal
Plus. Once the animal was confirmed to be dead by visually
examining the heart rate, dissection procedures were per-
formed. The knees were dissected, removing the skin and
muscle but maintaining the ligament connections at the knee.
The ACL, patellar tendon and BLB were isolated by re-
moving all other knee ligaments. To obtain ACLs and BLBs,
the tibia and femur were cut mid-bone to provide tissue for
gripping during mechanical testing. To obtain patellar ten-
dons, the patellar and tibial insertions of the patellar tendons
were carefully isolated keeping the patellar tendons intact.
The fat pad was then carefully removed from the patellar
tendons. For mechanical testing purposes, the portions of
patellar tendons that were not connected to both the tibia
and the patella were carefully removed, leaving the tendon
portions between patella and tibia insertions intact.
Histochemical and immunohistochemical analysis
of 3D BLB constructs and native ACLs
For staining, unfixed samples were placed into TBS me-
dium (Triangle Biological Sciences), frozen in cold iso-
pentane, and stored at - 80C until needed. Samples were
sliced to obtain cross and longitudinal sections with a cryo-
stat at a thickness of approximately 12mm, adhered to Su-
perfrost Plus microscopy slides and used for staining.
Sections were stained for general morphology observations
with hematoxylin and eosin (H&E). Highly mineralized ar-
eas of BLB/native bone interface were de-mineralized for *1
month in Formical-4 (Decal Chemical Corporation) before
embedding in TBS medium, sectioning and staining with
H&E. Immunofluorescent staining with specific antibodies
was performed to detect the presence of blood vessels
(anti-CD-31), nerves (anti-neural cell adhesion molecule
[anti-NCAM] and anti-S-100), collagen type 1, lymphocytes,
neutrophils and macrophages. Frozen sections were fixed
with ice cold methanol for 10 min and rinsed 3 times with
phosphate-buffered saline (PBS). Sections were blocked for
30 min with PBS-0.05% Tween20 (PBST) containing 20% calf
serum (PBST-S) at room temperature. Sections were incu-
bated overnight at 4C with the primary antibodies diluted
in PBST-S. The concentration of each of the primary anti-
bodies was as follows: 10mg/mL of rabbit anti-NCAM
(Millipore, Temecula, CA); 10mg/mL of rabbit anti-S-100,
10 mg/mL of rabbit antineutrophil elastase, 20mg/mL of
mouse antimacrophage (MAC387), 10 mg/mL of rabbit anti-
CD8 (all from Abcam); 10mg/mL of rabbit antimacrophage
scavenger receptor (Novus Biologicals); 10 mg/mL of rabbit
anti-CD31 (Abbiotec); and 5 mg/mL of rabbit anti-collagen
type 1 (Chemicon International). After three washes in PBST,
a 1-h room temperature incubation with Cy3-conjugated
anti-mouse or anti-rabbit antibody ( Jackson Im-
munoResearch Lab) was used for observation. After three
washes in PBST co-staining of sections with fluorescein-
labeled wheat germ agglutinin (5 mg/mL; Molecular Probes)
was used for general observation of the sample structure.
Nuclei were stained by 5 min incubation with DAPI solution
(Sigma) in PBST. The sections were examined and photo-
graphed with a Leica microscope.
Mechanical testing of BLB and native ACL
and patellar tendon viscoelasticity, tensile extensibility,
stiffness, and strength
Stress relaxation tests were conducted to obtain the vis-
coelastic responses of BLB and native ACL and patellar
tendon specimens using an RSA III Dynamic Mechanical
Analyzer (DMA) (TA Instruments) equipped with a 35 N
load cell. Before testing, the BLB and ACL were isolated from
the knee with the femur and tibia attached. Both femur and
tibia were trimmed to approximately 20 mm · 20 mm · 15
mm in order to fit into the DMA grips. Care was taken to
keep the soft tissue intact during the trimming process. Blue
Kote Aerosol (Dr. Naylor) was sprayed onto the specimen
surface for optical displacement measurement using digital
image correlation as shown in Figure 11. Measurements in-
cluding length, width and thickness were recorded before
the tests. The DMA was controlled using TA Orchestrator
software provided by TA Instruments. A Grasshopper IEEE-
1394b digital camera was employed for synchronized image
acquisition. The samples were subjected to two continuous
load-unload cycles at constant strain rate (0.01/s) followed
by stress relaxation at three different strain levels. Times,
loads and synchronized camera images were recorded.
During the tests, the specimens were kept in a hydrated state
by dripping DPBS onto the specimen.
Uniaxial tension testing was then conducted on the BLB
and ACL specimens from both operated and nonoperated
animals to obtain the tensile extensibility, stiffness and
strength using an MTS 810 servohydraulic test system with a
25 kN load cell. A 6 mm hole was drilled on the proximal end
of the femur and the distal end of the tibia. Two 6 mm
stainless steel bars were inserted into the holes drilled on the
bones for attachment to the metal grips on the MTS so that
the femur and tibia were fixed in a 0 of flexion angle. The
grips hung into a trough to submerge the specimen in saline
allowing testing in a hydrated state. Initially, there was no
pretension applied along the axis of the graft. A Grasshopper
IEEE-1394b digital camera was again used for synchronized
image acquisition. The samples were subjected to five con-
tinuous load-unload cycles at constant strain rate followed
by loading until failure and the synchronized force and im-
age recordings were compiled using LabVIEW. ImageJ and
Metamorph software were used for displacement calculation
via digital image correlation analysis of the camera image
data.
In vitro BLB constructs were tested using a customized
tensiometer designed in our lab and a 5 N load cell as de-
scribed previously.14,15 The samples were subjected to five
continuous load-unload cycles at constant strain rate fol-
lowed by loading until failure and the synchronized force
and image recordings were again compiled using LabVIEW.
Metamorph software was used for displacement calculation
via digital image correlation analysis of image data from a
Basler A102fc digital video camera.
In the mechanics experiments, the secondary slope of the
raw load versus particle displacement response curve
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determined the geometric stiffness. The data were then
converted to nominal stress (load/cross sectional area [CSA])
versus nominal strain (change in separation of image data/
initial separation). The (maximum) tangent stiffness was
determined by calculating the secondary slope of the nomi-
nal stress versus nominal strain response curve.
Results
Formation of BLB constructs in vitro
The BLB constructs were fabricated based on previously
published protocols with small modifications.14,42 Details can be
found in the Methods section. Our previous studies have shown
that the bone ends of the BLBs in vitro stain for mineralization
activity (Alizarin Red). We have also shown the absence of
markers for bone (Alizarin Red) and cartilage (Type II collagen)
in the mid-section of the BLB constructs. Newly formed bone
had areas of collagen-rich matrix with cells trapped inside the
matrix (arrow in Fig. 2A, B). The mid-sections stained for type I
collagen showed longitudinally oriented collagen fibers indi-
cating fibrogenic differentiation (Fig. 2C).
Growth of BLB constructs during ACL replacement
The dimensions of the ligament portion of the in vitro BLB
constructs before implantation (N = 7) were approximately
30–40 mm in intra-articular length and 3.0 – 0.2 mm in di-
ameter (7.1 – 1.0 mm2 in CSA). The BLB constructs we have
designed are viscoelastic and they contain contractile cells.
Before implantation they are longitudinally constrained and
carry an internal tensile stress. At the time of insertion into
the bone tunnel, they undergo viscoelastic deformation to
restore this passive tension. The initial compliance of the
intra-articular region of the BLB graft and its ability to
maintain self-tension allow it to accommodate knee motion
and not slip or develop slack. The sizes and structures of
adult native ACL were compared to that of our BLB explants
at the time of dissection at 2-, 3-, 4-, and 6-month recovery
time points (Fig. 3A–E). The native ligaments (Fig. 3F) were
taken from the contralateral knees of animals at the 6-month
recovery period time point. These results demonstrate that
the BLB constructs rapidly grew physically in cross section
during the initial implantation period and reached the size of
native adult ACL at about 4 months after implantation.
Analysis of structure, vascularization, and innervation
of the repaired ACL
After 6 months of implantation in vivo, we compared cross
sections at the centers of all BLB explants with those of the
native ACL. Figure 4 shows H&E staining of cross sections
through the centers of our BLB explants after 6 months
in vivo (N = 4). Figure 4A and B show the cross sections of the
BLB explants fabricated using frozen BMSCs whereas Figure
4C and D show the cross sections of the BLB explants fab-
ricated using fresh BMSCs. In constructs made from frozen
FIG. 2. Section of bone (A, B)
and ligament (C) portions of
BLB construct before implan-
tation stained with antibody
against collagen type 1 (red in
A–C) and nuclear stain DAPI
(blue in A–C). Arrows show
area of the newly formed bone
with cells trapped in the
collagen-rich matrix. DAPI,
4¢,6-diamidino-2-phenylindole.
FIG. 3. BLB construct in vitro (A) 30–40 mm in intra-articular length by 7.1 – 1.0 mm2 CSA, (N = 7); BLB explant in vivo at (B)
2 months: 17 mm long by 14 mm2 CSA (N = 1), (C) 3 months: 18 mm long by 28 mm2 CSA (N = 1) (D) 4 months: 18 mm by
64 mm2 CSA (N = 1) and (E) 6 months: 16.3 – 1.1 mm long by 57.5 – 48.7 mm2 CSA (N = 4); native adult ACL: 18.5 – 0.8 mm
long by 27.7 – 4.3 mm2 CSA (N = 3) (F). CSA, cross sectional area. Color images available online at www.liebertonline.com/tea
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cells (Fig. 4A, B), the center of the section contained viable
cells and was also highly vascularized (arrow in Fig. 4A, B),
suggesting that the BLB was fully viable and actively re-
modeling and growing but that more time was needed
in vivo to fully fill out the section with ligament tissue. In
constructs made from fresh cells (Fig. 4C), we see evidence of
the initial fascicle formation. In Figure 4D (arrows) we see a
fully remodeled BLB with collagen fascicle size and structure
that very closely resembles that seen in adult native ACL
(arrows in Fig. 4E). We analyzed frozen sections of the
middle portion of the BLB explants for the presence of both
blood vessels and nerves, using anti-CD31 and anti-NCAM
antibody immunostaining, respectively (Fig. 5). CD31 (PE-
CAM1) is a member of the immunoglobulin superfamily. It is
a major constituent of the endothelial cell intercellular junc-
tions and is considered to be a specific marker for blood
vessels. NCAM is expressed in all neurons from very early in
the development. It is considered to be a specific marker for
the neuronal cell bodies, axons, and dendrites. We found,
after a 3-month recovery, the midsection of the BLB-replaced
ACL contained an extensive vasculature (Fig. 5B). The vas-
culature was greater than that observed in adult tissues and
equivalent to that of a 14-day-old native neonatal sheep ACL
(Fig. 6E). Additionally, we observed innervation of nerve in
the midsection of the replaced ACL (Fig. 5C, F, I). After a 4-
month recovery, the midsection of the replaced ACL had
larger and more organized blood vessels and nerves (Fig. 5E,
F) and continued further organization of blood vessels and
nerves was seen after a 6-month recovery (Fig. 5H, I). H&E
staining of these same explants showed more organized col-
lagen fibers with time in vivo (Fig. 5A, D, G). These data
suggest that our tissue-engineered BLBs remodeled in vivo
with respect to mechanical structure (collagen alignment) and
biological function as indicated by the vascularization and
innervation. To compare the explants with native sheep lig-
aments, we stained frozen longitudinal tissue sections from
1-day, 14-day and adult sheep ACL for general structure,
vascularization, and innervation (Fig. 6). The innervation and
vascularization of the BLB explants at 6 months (Fig. 5H, I)
in vivo resembles that of the adult ACL (Fig. 6H, I).
Analysis of BLB/native bone interface
Figure 7 shows a demineralized longitudinal section of a
BLB explant after 2 months in vivo as an ACL replacement.
Within 2 months as an ACL replacement in the sheep, our
BLB constructs have integrated well with native tissue to
form a structurally viable and biochemically relevant en-
thesis. Sharpey’s fibers (white arrow in Fig. 7A) indicate in-
tegration of native bone with the engineered tissue. Aligned
nuclei (white arrow) indicative of a fibrocartilagenous region
are seen in Figure 7B.
Biomechanical stiffness and modulus analysis
of BLB explants and native ACL
We conducted mechanical loading tests by prescribing a
displacement ramp to a given strain level and then reversing
to zero strain at the same rate (a strain-controlled load-
unload tension test). The tangent modulus (the slope of the
stress–strain curve at specified strain range) of the BLB ex-
plants at 6 months (N = 3) averaged 130.0 – 17.2 MPa (strain
range: 0.10–0.35), the modulus of the contralateral ACL,
250.7 – 8.5 MPa (N = 3; strain range: 0.10–0.35), and the tan-
gent modulus of ACLs from nonoperated animals was found
to be 232 – 11 MPa (N = 2; strain range: 0.10–0.35), see Figure
8A. We also measured geometric stiffness (the slope of
the load-displacement curve at specified displacement) and
found 359.0 – 150.6 N/mm for the BLB explants and
379.2 – 73.6 N/mm for the contralateral ACL (Fig. 8B). The
geometric stiffness was a function of the CSA and compo-
sition of the graft, both of which varied in the developing
BLB explants at 6 months. Before implantation the BLB
constructs had a tangent modulus of 1.4 – 0.14 MPa (N = 3;
strain range: 0.2–0.3). These data indicate that after 6 months
in vivo as an ACL replacement, the BLB constructs increased
in mechanical properties by a factor of over 90 to attain 52%
of the tangent modulus and 95% of the geometric stiffness of
an adult contralateral ACL.
We measured the initial responses to an imposed strain of
0.15 in the BLB explants at 6 months versus the animal-
matched adult contralateral ACL (Fig. 8C, D). These data
FIG. 4. H&E staining of
cross-sections of BLB ex-
plants after 6 months of
implantation in vivo as an
ACL replacement (A–D)
and of native adult ACL (E).
The center of section (A, B)
made from frozen BMSCs
contained viable cells and
was highly vascularized
(arrow) but did not have
well formed collagen fasci-
cles. The cross section (C)
made from fresh cells
suggest possible collagen
fascicle formation. Explant
(D) made from fresh cells
also appeared to have fully remodeled with collagen fascicle size and structure that very closely resembled that seen in
adult native ACL in (E). H&E, hematoxylin and eosin. Color images available online at www.liebertonline.com/tea
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demonstrate that the initial stress–strain response of the BLB
explant at 6 months is more compliant in the 0% to 10%
strain range (the physiologically relevant in vivo range) but
that the load-displacement response curves of the BLB ex-
plant and the adult contralateral ACL are quantitatively and
qualitatively similar. The load-displacement results indicate
that at 6 months the BLB explants are capable of carrying
physiologically relevant loads, accurately matching the bio-
mechanics of adult ACL. The stress–strain results demon-
strate that the tissue of the BLB is not yet fully remodeled to
that of adult ACL because the BLB is more compliant than
the adult ACL. More time in vivo or a rehabilitation protocol
may allow complete remodeling of the BLB to an adult ACL
phenotype.
FIG. 6. Longitudinal sections
of neonatal and adult native
sheep ACL. Pictures of (A–C)
1-day-old, (D–F) 14-day-old and
(G–I) adult sheep ACL are
shown. (A, D, G) H&E staining
for observation of general
structure and collagen fibers;
arrows show blood vessels
found in tissue. (B, E, H) CD31
immunostaining for observation
of blood vessels; (C, F, I) S-100
immunostaining for observation
of nerves.
FIG. 5. Longitudinal sections
of BLB explants after (A–C) 3,
(D–F) 4, and (G–I) 6 months of
implantation in vivo as an ACL
replacement. (A, D, G) H&E
staining for observation of
general structure and collagen
fibers; arrows show blood
vessels found in tissue. (B, E,
H) CD31 immunostaining for
observation of blood vessels;
(C, F, I) NCAM immunostain-
ing for observation of nerves.
NCAM, neural cell adhesion
molecule; WGA, wheat germ
agglutinin.
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Native ACL, native patellar tendon
and BLB explant viscoelasticity
The nonlinear stress relaxation response of the BLB ex-
plants after 6 months as ACL replacements in the sheep
(N = 1) was compared to those of the native ACL in the
contralateral knee (N = 1) and to adult patellar tendons
(N = 2). The results for one animal-matched ACL and BLB
pair are shown in Figure 9A and B. The stress relaxation
response of the BLB explant is virtually indistinguishable
from that of the contralateral ACL indicating the BLB is ca-
pable of maintaining physiologically relevant viscoelastic
characteristics of adult ACL after 6 months as an ACL re-
placement in the sheep. The patellar tendon stress relaxation
results are shown in Figure 9C to differ from those of the
ACL and our BLB explants in important ways. The initial
rate of patellar tendon stress relaxation increases with in-
creased initial strain and the relaxation rate reaches a steady
state at long times, whereas for the ACL and the BLB explant
the rate of relaxation decreases with increased initial strain.
Strength of bone/graft and bone/ACL complexes
Three BLB explants at 6 months and contralateral ACLs
were loaded until failure after completion of the load-unload
and stress relaxation experiments. In all cases failure oc-
curred by failure of the tibia in the grip of the testing system;
therefore, no failure loads can be recorded for our BLB ex-
plants or the contralateral ACLs. However, the maximum
loads before bone failure in the grips occurred were recorded
and the average values are 676.3 – 356.4 N (N = 3) for the BLB
explants and 970.7 – 384.1 N (N = 3) for the contralateral
ACLs. The maximum loads expected in vivo are conserva-
tively estimated at 250 N (the load at 10% strain). Although
BLB strengths could not be determined, they clearly exceed
the in vivo loads. All of the seven implanted BLB constructs
integrated with native bone, and all survived the implanta-
tion experiments intact.
Native ACL and patellar tendon moduli
We conducted mechanical loading tests by prescribing a
displacement ramp to a given strain level and then reversing
to zero strain at the same rate (a strain-controlled load-
unload tension test). These load-unload experiments were
conducted on animal-matched ACLs and patellar tendons of
2-month-old (N = 2) and adult (N = 1) sheep (Fig. 10). Both
tissues exhibit nonlinear viscoelasticity with hysteresis in the
load-unload response. At small strains the stress–strain re-
sponse curves of the patellar tendon and ACL diverge and
the patellar tendon is seen to have a higher tangent modulus
(slope of the stress–strain loading curve as shown for ex-
ample by the gray line segments in Fig. 10) at all strain levels
beyond 0.002 (0.2%). These data are in agreement with recent
data on patient-matched human ACLs and patellar tendons,
which also demonstrated a greater tangent modulus for the
patellar tendon.17
FIG. 8. Modulus and stiffness of BLB explants after 6
months of implantation and contralateral ACLs of adult
sheep. (A) Tangent modulus of the linear portion of the
stress–strain response curves over a strain range of 0.10–0.35.
(B) Corresponding geometric stiffness (C) Stress–strain rela-
tionship and (D) Load-displacement curves detailing the
initial responses (physiological or < 5% strain) of BLB ex-
plants and adult contralateral ACLs.
FIG. 7. BLB explant/native
bone interface 2 months after
implantation in vivo as an
ACL replacement. Two
sections of the BLB explant
shows (A) integration into
native bone through the
Sharpey’s fibers (arrow) and
(B) fibrocartilaginous region
with aligned nuclei (arrow).
Color images available online
at www.liebertonline.com/tea
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Analysis of body fluids and tissue sections
for signs of immune rejection
Samples of blood (3 months) urine (3 months) and syno-
vial fluid (3, 4, and 6 months) were obtained before dissec-
tion from ACL repaired and contralateral (control) knees.
These were analyzed for an increase in white blood cell count
and the presence of neutrophils and macrophages as indi-
cators of an infection and a mounted immune response
against the implanted tissue. The hematology, urinalysis re-
ports and histological analysis of synovial fluid were unre-
markable and showed no indications of infection or immune
rejection in these animals. During dissection, portions of the
engineered ligament were frozen, subsequently sectioned
and stained for the presence of neutrophils and macro-
phages. We did not detect the presence of neutrophils or
macrophages in any of the BLB grafts examined. Sections of
spleen were used as a positive control.
Discussion
We have developed a multi-phasic, engineered BLB con-
struct with a viable, intact bone–ligament interface in vitro
and the capacity to become vascularized and innervated
when implanted in sheep, with complete ligamentization
and mechanical properties comparable to those of adult
ACL. Our multi-phasic engineered ligament and bone tissues
can be fabricated from an autogenic source but without the
donor site morbidity associated with patellar tendon and
hamstring autografts. Tissue availability is not a limiting
factor with this approach due to a plentiful and easily ac-
cessible allogenic cell source as well. The lack of immune
rejection of our constructs after implantation indicates that
allogenic rather than autogenic sources of BMSCs may be
used.
The elasticity requirements of engineered ligament at the
time of replacement remain under debate.20,43–45 The current
paradigm is to match or exceed native ligament stiffness and
strength in order to immediately restore stability to the
knee.44 However, recent evidence suggests stiff scaffolds
shield the cells within these structures from strains required
for proper signal induction and, hence, growth of neoliga-
mentous tissue.20,44,45 The result is loss of cell viability with
time in vivo and increased joint laxity.43,45 Moreover, the
stresses during normal ACL function do not typically exceed
20% of ACL strength43 suggesting that current engineering
approaches are over-designed for strength, especially if
eventual collagen growth and remodeling is expected with
time. Therefore, an engineered ligament that is compliant
upon implantation such that its cells are not strain shielded
would promote cell growth, remodeling of tissues and
eventual ligamentization. In our approach, the animals were
not restrained during healing. During the early healing pe-
riod, the BLB implants do not need to sustain a physiological
load, they need to be able to accommodate knee motion
without tearing. Because our BLBs are compliant initially,
they can sustain a physiological length change during knee
motion. Also, because they are viscoelastic, they recover that
length change upon unloading. The BLB constructs were
fabricated at a slightly larger length than the expected intra-
articular span and at the time of implantation the ends of the
bone sections were aligned with the insertion edges of the
bones, allowing the intra-articular region to quickly (within
seconds) retension itself, providing a perfect patient-specific
fit. This allowed us to fabricate one size construct for any size
knee.
Current ACL grafts often do not fully heal at the bone
tunnel even after 2 years and may display joint laxity and
graft failure.46,47 In contrast we have established very rapid
(within 2 months) integration of the constructs with native
FIG. 10. Stress–strain response curves of a patellar tendon
and an ACL from the same animal. Color images available
online at www.liebertonline.com/tea
FIG. 9. Stress relaxation as a function of initial strain for animal-matched (A) ACL and (B) BLB explant in adult sheep and
(C) adult patellar tendon. Color images available online at www.liebertonline.com/tea
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bone (Fig. 7) and healing of our multi-phasic BLB constructs
in the bone tunnel (see Fig. 3B–E). Therefore, the need to
protect our grafts in the bone tunnel (i.e., by delayed or mild
physical therapy or via metal fixation screws) is diminished.
Well-integrated bone ends allowed rapid growth in vivo
(within 3 months) of vascularization and innervation in vivo.
After 6 months of in vivo recovery, we have shown that the
BLB grafts can sustain very large loads, well-beyond physi-
ological limits, and also the same load magnitudes that the
contralateral ACLs can withstand. The average CSA of the
in vivo BLB 57.5 – 48.7 mm2 and the CSA of the contralateral
ACL is 27.7 – 4.3 mm2. The initial CSA of the BLBs before the
surgery is 7.1 – 1.0 mm2. The size of the bone tunnel needed
to accommodate the BLB graft was less than that typically
used clinically (see Methods section). Our results suggest the
thinner bone tunnel may heal faster and it may accelerate the
growth and remodeling of the BLBs. Therefore, the impli-
cation of BLBs increasing in size in vivo over time is signifi-
cant. We demonstrate that a full-sized graft is not needed if it
can develop rapidly in vivo. Statistically, the 6 month in vivo
BLB is not significantly larger than native ACL. The large
standard deviation is due to the large CSA of one BLB ex-
plant. At present, the issue of overgrowth of the BLB is not of
concern. At each time point examined thus far (2, 3, 4, and 6
months), the issue of growth and size has not been a negative
factor. The ligaments have fit well into the femoral notch and
do not appear to be growing disproportionally.
At 6 months in vivo the vascularization of the BLB closely
resembled that of the adult ACL. Vascularization is a process
essential to growth and remodeling of our BLB construct.
During regeneration of the injured ligament, pathways for
repair are similar to those observed during development, as
indicated by our analysis of developing sheep at one day, 14
days and adult to compare our regenerating tissue to those of
developing ACL, enthesis and bone (Figs. 6 and 7). The de-
velopment of the BLB appears to recapitulate the develop-
mental processes observed in developing native ACL.
A human ACL can sustain a load of 2000 N before rup-
turing.48 Some investigators believe that the ability to with-
stand such loads without rupture during extension of the
knee is due to activation of an ACL-hamstring reflex arc and
subsequent contraction of the hamstrings muscles that
counterbalances the forces of the quadriceps on the tibia and
prevents the rupture of the ACL.35 This reflex arc is de-
stroyed during the severing of the ACL and is usually not
reinnervated with patellar or hamstring tendon grafts. While
the contribution of the ACL-hamstrings reflex arc to pro-
prioception and its role in the prevention of ACL rupture is
controversial,49,50 the functional innervation observed in
some models of repair will only further enhance the recovery
potential of the ACL.49,50 In our BLB grafts, we have ob-
served innervation of the grafts as early as 3-months after
implantation (see Fig. 6), although we do not yet know
whether this innervation is functional. Ongoing studies in
our laboratory are investigating the return of the ACL eli-
cited electromyography activity in the hamstrings muscle
and the recovery of native kinematics as a results of the
observed innervation.
The tangent modulus of ACLs from nonoperated animals
was found to be 232 – 11 MPa (N = 2). The moduli of non-
operated animals were not significantly different from
those of the contralateral ACLs from operated animals. We
have compared our modulus results with values from lit-
erature.38–40 The reported geometric stiffness values for
sheep ACL were converted to tangent moduli using the
geometric properties provided38–40 and the average value
found to be 130 – 15 MPa. This value is lower than our re-
sults and the differences are due to the fact that we measure
the actual tissue level displacement directly and non-
invasively whereas the literature results recorded the grip-
to-grip displacement that neglected the compliance within
the system and nonphysiological issues associated with
mechanical testing such as slip, tearing and stress concen-
trations at the grips.
The patellar tendon autograft is a common source of tissue
for ACL repair. Recently the biomechanical properties of the
ACL and the patellar tendon have been compared within the
physiological range of 5% strain16,17 and the results suggest
that current ACL grafts are often over-designed for stiffness
(Fig. 10). Our multi-phasic constructs rapidly increased
stiffness and strength in vivo in response to stresses and
strains placed on them to attain physiologically relevant
mechanics. We believe the initial compliance of the intra-
articular region of the graft allowed the graft to strain at
relatively low stress levels. This deformability was conducive
to mechanotransduction of the cells within the intra-articular
region. It had the added benefit of transferring very low
loads to the regions of the graft within the bone tunnels in
the weeks after surgery during which bone tunnel healing
occurs, eliminating the need for metal fixation screws to hold
the graft in place. At 6 months as an ACL replacement in the
sheep some of the BLB grafts contained fascicles of type I
collagen that were highly aligned and resembled the collagen
fascicle structure and alignment of native adult ACL.
FIG. 11. RSA III Dynamic
Mechanical Analyzer evalu-
ation of stress relaxation.
evaluation of (A) BLB
explant and adult
contralateral (B) ACL.
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Moreover, native ACL has a characteristic viscoelastic re-
laxation response that is not shared by patellar tendon grafts;
our multi-phasic BLB constructs did exhibit qualitatively and
quantitatively similar stress relaxation responses to those of
native ACL. These results indicate that the patellar tendon is
not an ideal biomechanical replacement for the ACL, not
only because it is too stiff, but also because its time depen-
dent properties are very different at the time of implantation
from those of native ACL. This has important implications
for the risk of re-injury when using a patellar tendon graft,
especially at high strain rates of loading such as in an impact
event, because the viscoelastic or time dependent properties
govern the high strain rate response. It is not known whether
the patellar tendon graft develops and maintains the proper
viscoelastic response over time, but it is clear that its visco-
elastic response is initially fundamentally different from that
of native ACL. The relevance of the patellar tendon data is
that it isn’t biomechanically similar to ACL despite the fact
that the patellar tendon is adult, native connective tissue. The
goal is also to establish that the BLB constructs have the
proper nonlinear viscoleastic properties compared to those of
native tissue which are not matched by current ACL repair
techniques utilizing patellar tendon grafts. This result has the
further significance of addressing how arduous a task it is to
accurately match the very important nonlinear viscoelastic
properties of the native ACL with a graft-engineered or
otherwise.
Tissue engineering grafts for ACL repair has been in-
creasingly focused recently. For instance, Cooper et al.
(2007) has developed synthetic braided scaffolds as grafts
for ACL repair.51 Synthetic scaffolds are not needed in our
method. One of the disadvantages of using synthetic scaf-
fold is that its degradation rates in vivo often exceed the
desired rates. Infiltration of collagen fibers are seen in these
types of scaffolds in vivo; however, the overall mechanical
properties decrease rapidly over time because of the rapidly
biodegrading scaffold. On the other hand, our scaffold-less
self-assembled BLB grafts grow rapidly in vivo and the
mechanics of the in vivo BLB have increased a factor of 90
compared to that of the in vitro BLB before the implantation.
In addition, the integration of ends to native bone was not
evaluated in Cooper et al. (2007). There is no evidence
showing that the synthetic graft formed a strong enthesis
between the graft and the native bone, whereas our BLB has
shown markers of enthesis early after 2 months of im-
plantation.
In conclusion, the biomechanical requirements of an ACL
graft at the time of implantation were examined with the aim
of developing an engineered ACL graft that would rapidly
grow and remodel in vivo to present the histological and
biomechanical characteristics of adult, native ACL. We have
demonstrated that our BLB constructs, with their initially
compliant intra-articular region, do not require fixation
screws to achieve a rapid in vivo interface with native bone,
become vascularized and innervated. Some of the BLB con-
structs develop highly organized collagen fascicles and after
6 months in vivo, exhibit physiologically relevant viscoelastic
properties of adult ACLs. The viscoelastic properties of an
ACL graft have been largely overlooked previously but they
are a critical aspect of the restoration of biomechanical
function to prevent graft failures. Our ongoing studies will
compare the nonlinear viscoelastic characteristics of BLB
grafts to patellar tendon autografts at longer recovery time
points.
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